{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:46:39Z","timestamp":1786992399431,"version":"build-2736575974"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2021YFC2701800"],"award-info":[{"award-number":["2021YFC2701800"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2021YFC2701803"],"award-info":[{"award-number":["2021YFC2701803"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jgar.2026.04.002","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T16:35:43Z","timestamp":1776011743000},"page":"101-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Ceftazidime-avibactam-based regimens for the treatment of central nervous system infections caused by carbapenem-resistant Klebsiella pneumoniae in a paediatric patient"],"prefix":"10.1016","volume":"49","author":[{"given":"Liming","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5526-1502","authenticated-orcid":false,"given":"Xiaofen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangfeng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2966-9149","authenticated-orcid":false,"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2026.04.002_bib0001","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.cmi.2016.01.007","article-title":"ESCMID guideline: diagnosis and treatment of acute bacterial meningitis","volume":"22","author":"Van de Beek","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.jgar.2026.04.002_bib0002","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13756-021-00895-x","article-title":"Prevalence and antimicrobial resistance patterns of bacteria isolated from cerebrospinal fluid among children with bacterial meningitis in China from 2016 to 2018: a multicenter retrospective study","volume":"10","author":"Peng","year":"2021","journal-title":"Antimicrob Resist Infect Control"},{"issue":"3","key":"10.1016\/j.jgar.2026.04.002_bib0003","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00253-22","article-title":"Carbapenem-resistant gram-negative bacteria-related healthcare-associated ventriculitis and meningitis: antimicrobial resistance of the pathogens, treatment, and outcome","volume":"10","author":"Ye","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"6","key":"10.1016\/j.jgar.2026.04.002_bib0004","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s40265-018-0902-x","article-title":"Ceftazidime-avibactam: a review in the treatment of serious gram-negative bacterial infections","volume":"78","author":"Shirley","year":"2018","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.jgar.2026.04.002_bib0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/cid\/ciac268","volume":"75","author":"Tamma","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jgar.2026.04.002_bib0006","doi-asserted-by":"crossref","first-page":"106777","DOI":"10.1016\/j.ijantimicag.2023.106777","article-title":"Ceftazidime-avibactam-based combination therapy for hospital-acquired central nervous system infections caused by carbapenem-resistant Klebsiella pneumoniae","volume":"61","author":"Zhao","year":"2023","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"10.1016\/j.jgar.2026.04.002_bib0007","doi-asserted-by":"crossref","first-page":"ofaa349","DOI":"10.1093\/ofid\/ofaa349","article-title":"Using therapeutic drug monitoring to treat KPC-producing Klebsiella pneumoniae Central nervous system infection with Ceftazidime\/Avibactam","volume":"7","author":"Yasmin","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.jgar.2026.04.002_bib0008","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/INF.0000000000003439","article-title":"Ceftazidime-avibactam for the treatment of multidrug-resistant Pseudomonas aeruginosa Central nervous system infection in pediatric patient: a case report","volume":"41","author":"Almangour","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jgar.2026.04.002_bib0009","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.2147\/IDR.S403527","article-title":"Ceftazidime-avibactam treatment for severe post-neurosurgical meningitis and abscess caused by extended-spectrum \u03b2-lactamase Escherichia coli in a pediatric patient: a case report","volume":"16","author":"Ren","year":"2023","journal-title":"Infect Drug Resist"},{"issue":"6","key":"10.1016\/j.jgar.2026.04.002_bib0010","doi-asserted-by":"crossref","first-page":"107356","DOI":"10.1016\/j.ijantimicag.2024.107356","article-title":"Pharmacodynamic target attainment at infection site during treatment of post-neurosurgical ventriculitis caused by carbapenem-resistant klebsiella pneumoniae with ceftazidime-avibactam-based regimens: a case report","volume":"64","author":"Chen","year":"2024","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"10.1016\/j.jgar.2026.04.002_bib0011","doi-asserted-by":"crossref","first-page":"1196.e1191","DOI":"10.1016\/j.cmi.2023.06.002","article-title":"Plasma and intraperitoneal pharmacokinetics of ceftazidime\/avibactam in peritoneal dialysis patients","volume":"29","author":"Al Jalali","year":"2023","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.jgar.2026.04.002_bib0012","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/INF.0000000000002344","article-title":"Use of Ceftazidime-avibactam for the treatment of extensively drug-resistant or pan drug-resistant Klebsiella pneumoniae in neonates and children <5 years of age","volume":"38","author":"Iosifidis","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"02","key":"10.1016\/j.jgar.2026.04.002_bib0013","first-page":"109","article-title":"Consensus of Chinese experts on topical application of polymyxin in severe central nervous system infections (2024)","volume":"23","year":"2024","journal-title":"Chin J Neuromed"},{"key":"10.1016\/j.jgar.2026.04.002_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1444172","article-title":"Ceftazidime\/avibactam combined with colistimethate sodium successfully cures carbapenem-resistant pseudomonas aeruginosa-induced brain abscess in a child post-craniotomy: a case report","volume":"14","author":"Yuan","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.jgar.2026.04.002_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1532608","article-title":"Treatment of pediatric central nervous system infection caused by carbapenem-resistant Klebsiella pneumoniae with ceftazidime\/avibactam, two cases report and literature review","volume":"16","author":"Qing","year":"2025","journal-title":"Front Pharmacol"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526000524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526000524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:30:15Z","timestamp":1781767815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716526000524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":15,"alternative-id":["S2213716526000524"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2026.04.002","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ceftazidime-avibactam-based regimens for the treatment of central nervous system infections caused by carbapenem-resistant Klebsiella pneumoniae in a paediatric patient","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2026.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}